Mettler-Toledo International (NYSE:MTD) Price Target Raised to $1,450.00

Mettler-Toledo International (NYSE:MTD) had its price objective upped by Wells Fargo & Company from $1,400.00 to $1,450.00 in a report released on Monday morning,Benzinga reports. Wells Fargo & Company currently has an equal weight rating on the medical instruments supplier’s stock.

Several other brokerages also recently weighed in on MTD. Bank of America upgraded Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price target for the company in a report on Monday. Citigroup increased their target price on Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the stock a “buy” rating in a research report on Monday, November 10th. JPMorgan Chase & Co. raised their price target on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the stock a “neutral” rating in a research note on Thursday, October 9th. Evercore ISI upped their price objective on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an “outperform” rating in a research note on Tuesday, October 7th. Finally, The Goldman Sachs Group assumed coverage on shares of Mettler-Toledo International in a report on Tuesday, December 9th. They set a “neutral” rating and a $1,475.00 price objective on the stock. Six investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $1,441.67.

Mettler-Toledo International Trading Down 0.1%

Shares of MTD stock opened at $1,384.84 on Monday. Mettler-Toledo International has a twelve month low of $946.69 and a twelve month high of $1,525.17. The company has a market capitalization of $28.29 billion, a price-to-earnings ratio of 34.53, a PEG ratio of 4.48 and a beta of 1.40. The firm has a 50-day moving average price of $1,406.27 and a 200 day moving average price of $1,297.87.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 EPS for the quarter, topping analysts’ consensus estimates of $10.62 by $0.53. The business had revenue of $1.03 billion during the quarter, compared to the consensus estimate of $997.36 million. Mettler-Toledo International had a net margin of 21.20% and a negative return on equity of 426.96%. The company’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $10.21 earnings per share. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. As a group, research analysts predict that Mettler-Toledo International will post 42.71 earnings per share for the current year.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, Director Elisha W. Finney sold 474 shares of the business’s stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $1,433.57, for a total transaction of $679,512.18. Following the completion of the sale, the director directly owned 311 shares in the company, valued at $445,840.27. The trade was a 60.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider La Guerroniere Marc De sold 6,055 shares of the stock in a transaction on Tuesday, November 25th. The stock was sold at an average price of $1,488.18, for a total transaction of $9,010,929.90. Following the completion of the sale, the insider directly owned 187 shares of the company’s stock, valued at $278,289.66. The trade was a 97.00% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 19,565 shares of company stock worth $28,683,737. Company insiders own 1.94% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of MTD. Bank of New York Mellon Corp boosted its position in shares of Mettler-Toledo International by 71.3% in the second quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier’s stock worth $1,062,257,000 after buying an additional 376,419 shares during the period. Norges Bank purchased a new position in Mettler-Toledo International in the 2nd quarter worth approximately $360,126,000. Alliancebernstein L.P. grew its position in Mettler-Toledo International by 21.6% in the first quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier’s stock valued at $837,653,000 after acquiring an additional 126,147 shares in the last quarter. PineStone Asset Management Inc. grew its position in Mettler-Toledo International by 41.9% in the second quarter. PineStone Asset Management Inc. now owns 334,349 shares of the medical instruments supplier’s stock valued at $392,766,000 after acquiring an additional 98,737 shares in the last quarter. Finally, Rakuten Investment Management Inc. purchased a new stake in shares of Mettler-Toledo International during the third quarter valued at approximately $121,021,000. Institutional investors and hedge funds own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.